2020
Ophthalmic Medication Expenditures and Out-of-Pocket Spending An Analysis of United States Prescriptions from 2007 through 2016
Chen EM, Kombo N, Teng CC, Mruthyunjaya P, Nwanyanwu K, Parikh R. Ophthalmic Medication Expenditures and Out-of-Pocket Spending An Analysis of United States Prescriptions from 2007 through 2016. Ophthalmology 2020, 127: 1292-1302. PMID: 32359935, PMCID: PMC7508869, DOI: 10.1016/j.ophtha.2020.04.037.Peer-Reviewed Original ResearchConceptsOphthalmic medicationsMedication expendituresOOP expenditureLongitudinal cohort studyOverall drug expendituresUnited States populationPrescription drug spendingGlaucoma medicationsCohort studyMedication useDry eyePrescription usePrescription expendituresPrescription medicationsOOP expensesMedicationsCopayment assistancePocket expenditureOOP spendingDrug expendituresPocket spendingDrug spendingIndirect costsMEPS participantsLinear regression
2009
Factors Affecting Rates of Visual Field Progression in Glaucoma Patients with Optic Disc Hemorrhage
Prata TS, De Moraes CG, Teng CC, Tello C, Ritch R, Liebmann JM. Factors Affecting Rates of Visual Field Progression in Glaucoma Patients with Optic Disc Hemorrhage. Ophthalmology 2009, 117: 24-29. PMID: 19896197, DOI: 10.1016/j.ophtha.2009.06.028.Peer-Reviewed Original ResearchConceptsDB/yearDisc hemorrhageOptic disc hemorrhageVisual field progressionDH detectionVF lossFaster progressionBaseline MDGlaucoma patientsRisk factorsField progressionOdds ratioPresence of DHMultivariate logistic regression analysisRetrospective cohort studyConsecutive glaucoma patientsSignificant risk factorsSwedish Interactive Threshold AlgorithmConfidence intervalsImportant risk factorRate of progressionGlaucoma Progression StudyLogistic regression analysisAggressive treatmentCohort study